158 related articles for article (PubMed ID: 15113059)
1. Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver.
Weishaupt D; Willmann JK; Lutz AM; Marincek B
Eur Radiol; 2004 Jan; 14 Suppl 1():C5-6. PubMed ID: 15113059
[No Abstract] [Full Text] [Related]
2. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.
Qayyum A; Thoeni RF; Coakley FV; Lu Y; Guay JP; Ferrell LD
J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
5. Double contrast MR imaging of hepatocellular carcinoma evaluating lesion detection and conspicuity.
Akinci D; Oto A; Besim A; Akhan O; Abbasoglu O; Batman F; Eryilmaz M
Acad Radiol; 2002 Aug; 9 Suppl 2():S466-7. PubMed ID: 12188310
[No Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
[TBL] [Abstract][Full Text] [Related]
8. [MR contrast agent: resovist (SH U 555A)].
Nakajima H; Ichikawa T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
[No Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
Hammerstingl R; Vogl TJ; Schwarz W; Kümmel S; Balzer T; Neuhaus P; Felix R
Acad Radiol; 1998 Apr; 5 Suppl 1():S75-9; discussion S93-4. PubMed ID: 9561049
[No Abstract] [Full Text] [Related]
11. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
[TBL] [Abstract][Full Text] [Related]
12. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging.
Mori K; Scheidler J; Helmberger T; Holzknecht N; Schauer R; Schirren CA; Bittmann I; Dugas M; Reiser M
AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063
[TBL] [Abstract][Full Text] [Related]
13. SPIO-MRI in the detection of hepatocellular carcinoma.
Araki T
J Gastroenterol; 2000; 35(11):874-6. PubMed ID: 11085500
[No Abstract] [Full Text] [Related]
14. [Imaging nodules within cirrhotic liver: how do I do it?].
Luciani A; Allice O; Zegai B; Djabbari M; Anglade MC; Rahmouni A; Cherqui D; Tran-Van-Nhieu J; Aubé C
J Radiol; 2007; 88(7-8 Pt 2):1073-90. PubMed ID: 17762836
[TBL] [Abstract][Full Text] [Related]
15. Perfusion study of hypervascular hepatocellular carcinoma with SPIO.
Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
Magn Reson Med Sci; 2005 Dec; 4(4):151-8. PubMed ID: 16543699
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
17. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
[No Abstract] [Full Text] [Related]
18. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
[TBL] [Abstract][Full Text] [Related]
19. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.
Matsuo M; Kanematsu M; Itoh K; Ito K; Maetani Y; Kondo H; Kako N; Matsunaga N; Hoshi H; Shiraishi J
AJR Am J Roentgenol; 2001 Sep; 177(3):637-43. PubMed ID: 11517061
[TBL] [Abstract][Full Text] [Related]
20. [Obsolete methods in examination of the liver with MRI].
Schadmand-Fischer S
Rofo; 1998 Dec; 169(6):679-80. PubMed ID: 9930229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
